Find uplifting stories about heroes, innovations, and solutions
6066 results for "leukemia treatment"
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
A breakthrough combination therapy is giving aggressive leukemia patients new hope, nearly doubling remission rates and opening the door to life-saving transplants. The treatment developed in Germany could soon become the new standard of care.
Google's new AI system just helped discover promising leukemia treatments that actually worked in laboratory experiments. This isn't science fiction anymore—it's real progress happening right now in cancer research.
Researchers at Memorial Sloan Kettering developed a groundbreaking CAR T cell therapy that targets leukemia while sparing healthy blood cells. The innovation came from studying patients whose cancer went into long-term remission.
Chinese scientists created a simple add-on that makes failing cancer treatments work again, without expensive genetic engineering. Patients who relapsed after CAR T therapy could now get a second chance at survival.
A new AI system called Co-Scientist just helped researchers discover promising new treatments for acute myeloid leukemia that worked in laboratory experiments. The breakthrough shows how artificial intelligence can speed up the slow, expensive process of finding new medical cures.
Researchers at University of Chicago discovered why a mutation makes adult leukemia so resistant to treatment and identified a strategy that could extend survival by a year. The breakthrough could reshape how doctors treat one in 10 adult leukemia patients.
Researchers at the University of Oslo have found a way to halt cancer stem cells in acute myeloid leukemia by targeting a molecule previously thought to worsen the disease. The breakthrough could lead to personalized treatments that stop cancer before it spreads.
Scientists discovered how to permanently switch off cancer-causing genes, potentially shortening treatment and reducing harsh side effects. The breakthrough targets aggressive leukemia and enters clinical trials this year.
Young leukemia patients are beating cancer at remarkable rates thanks to a groundbreaking Australian treatment that swaps harsh chemo for immune therapy. Nearly 9 in 10 patients remain cancer-free three years later.
A husband-and-wife research team turned their midnight lab conversations at the University of Virginia into ziftomenib, a newly FDA-approved drug now saving lives of leukemia patients who had run out of options. Their 17-year journey from academic research to life-saving treatment shows how university labs can tackle diseases others overlook.
A groundbreaking blood test can predict which leukemia patients are most likely to relapse after bone marrow transplants, helping doctors personalize treatment. The discovery could transform care for thousands battling this aggressive blood cancer.
Scientists at Emory University are developing a targeted treatment for childhood leukemia that could save young lives without the harsh side effects of traditional chemotherapy. The new approach attacks cancer cells precisely, sparing hair follicles, healthy tissues, and long-term quality of life.
A new targeted therapy for chronic myeloid leukemia achieved major molecular responses in nearly half of patients with advanced disease. The drug, ELVN-001, performed even better in patients treated earlier, offering fresh hope in the fight against this slow-growing blood cancer.
When Britt Mayo was diagnosed with leukemia in 2010, one conversation about his life priorities helped him avoid chemotherapy and qualify for a trial that led to remission. Now he's helping other patients learn they have choices in their cancer care.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
Showing 20 of 6066